Rob Carlson
Gründer bei Bioeconomy Capital LLC
Profil
Rob Carlson is the founder of Bioeconomy Capital LLC, which was founded in 2014.
He is currently a Director at RoosterBio, Inc. since 2013 and a Director at Lumen Bioscience, Inc. He previously worked as an Advisor at Samurai Sword Corp., a Senior Scientist at the University of Washington, and a Scientific Advisor at The Hastings Center.
Dr. Carlson received his undergraduate degree from the University of Washington and his doctorate from Princeton University.
Aktive Positionen von Rob Carlson
| Unternehmen | Position | Beginn |
|---|---|---|
Bioeconomy Capital LLC
 Bioeconomy Capital LLC Investment ManagersFinance Bioeconomy Capital LLC (Bioeconomy Capital) is a venture capital firm founded in 2014 by Rob Carlson and Rik Wehbring. The firm is headquartered in Seattle, Washington. | Gründer | 01.01.2014 |
Lumen Bioscience, Inc.
 Lumen Bioscience, Inc. Pharmaceuticals: OtherHealth Technology Lumen Bioscience, Inc. operates as a clinical stage biotechnology company which engages in the manufacture of therapeutic biologics for oral delivery. It focuses on the development of the blue-green algae Spirulina as an industrial scale production platform. The company was founded by Brian Finrow and James Roberts in 2017 and is headquartered in Seattle, WA. | Direktor/Vorstandsmitglied | - |
RoosterBio, Inc.
 RoosterBio, Inc. BiotechnologyHealth Technology RoosterBio, Inc. provides standardized stem cell platforms that enable clinical and commercial translation. Its products include bioprocess media, plug and play systems, clinical control, and roosterbio swag products. The company was founded Jon A. Rowley in 2013 and is headquartered in Frederick, MD. | Direktor/Vorstandsmitglied | 01.07.2013 |
Ehemalige bekannte Positionen von Rob Carlson
| Unternehmen | Position | Ende |
|---|---|---|
Samurai Sword Corp.
 Samurai Sword Corp. BiotechnologyHealth Technology Samurai Sword Corp. generates biochemical and bioenergy products. Its AGATE (Acid, Gas, and Ammonia Targeted Extraction) technology utilizes modified anaerobic fermentation (like brewing beer) and non-GMO bacterial consortia to produce biochemicals, biomethane, biohydrogen, and nitrogen compounds. The company was founded by Kelly M. Ogilvie and James Stephens in 2005 and is headquartered in Missoula, MT. | Corporate Officer/Principal | - |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
| The Hastings Center | Corporate Officer/Principal | - |
Ausbildung von Rob Carlson
| University of Washington | Undergraduate Degree |
| Princeton University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Samurai Sword Corp.
Samurai Sword Corp. BiotechnologyHealth Technology Samurai Sword Corp. generates biochemical and bioenergy products. Its AGATE (Acid, Gas, and Ammonia Targeted Extraction) technology utilizes modified anaerobic fermentation (like brewing beer) and non-GMO bacterial consortia to produce biochemicals, biomethane, biohydrogen, and nitrogen compounds. The company was founded by Kelly M. Ogilvie and James Stephens in 2005 and is headquartered in Missoula, MT. | Health Technology |
RoosterBio, Inc.
RoosterBio, Inc. BiotechnologyHealth Technology RoosterBio, Inc. provides standardized stem cell platforms that enable clinical and commercial translation. Its products include bioprocess media, plug and play systems, clinical control, and roosterbio swag products. The company was founded Jon A. Rowley in 2013 and is headquartered in Frederick, MD. | Health Technology |
| The Hastings Center | |
Bioeconomy Capital LLC
Bioeconomy Capital LLC Investment ManagersFinance Bioeconomy Capital LLC (Bioeconomy Capital) is a venture capital firm founded in 2014 by Rob Carlson and Rik Wehbring. The firm is headquartered in Seattle, Washington. | Finance |
Lumen Bioscience, Inc.
Lumen Bioscience, Inc. Pharmaceuticals: OtherHealth Technology Lumen Bioscience, Inc. operates as a clinical stage biotechnology company which engages in the manufacture of therapeutic biologics for oral delivery. It focuses on the development of the blue-green algae Spirulina as an industrial scale production platform. The company was founded by Brian Finrow and James Roberts in 2017 and is headquartered in Seattle, WA. | Health Technology |
